Neurofilament light chain (NfL), a key component of neuronal and axonal cytoskeleton proteins, is elevated not only in MS but also in other CNS diseases, serving as a general indicator of axonal damage regardless of the underlying cause (1). The gene discussed is NEFL; the disease is myeloid sarcoma.